Immatics N.V. (NASDAQ: IMTX)
$7.1350
+0.0750 ( +1.93% ) 82.8K
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
Market Data
Open
$7.1350
Previous close
$7.0600
Volume
82.8K
Market cap
$858.14M
Day range
$6.9100 - $7.2790
52 week range
$6.6800 - $13.7700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 1 | Dec 13, 2024 |
| 6-k | Form 6-K | 111 | Nov 18, 2024 |
| 6-k | Form 6-K | 92 | Nov 08, 2024 |
| 6-k | Form 6-K | 10 | Oct 15, 2024 |
| 6-k | Form 6-K | 118 | Oct 10, 2024 |
| 6-k | Form 6-K | 110 | Sep 16, 2024 |
| 6-k | Form 6-K | 78 | Aug 13, 2024 |
| 6-k | Form 6-K | 1 | Jul 31, 2024 |
| 6-k | Form 6-K | 2 | Jun 20, 2024 |
| 6-k | Form 6-K | 7 | Jun 03, 2024 |